Africa – Cities where the Website is accessed (08.2010 – 07.2011) The Global Dermatology Information Portal is accessed in the following cities (top 10): Eastern Africa St-Denis Port Louis Antananarivo St Paul Le Port Kigali Bujumbura Djibouti Nairobi Maputo Northern Africa Tunis Algiers Casablanca Rabat Casablanca Sidi Bel Abbes Cairo Setif Agadir Constantine Southern Africa…
DetailsNorth America and South America – Cities where the Website is accessed (08.2010 – 07.2011) The Global Dermatology Information Portal is accessed in the following cities (top 10): Caribbean Fort-de-France Baie Mahault Port Au Prince Pointe-a-Pitre Santo Domingo Port of Spain Kingston Mayaguez Santiago de Los Caballeros Havana Central America Mexico City Guadalajara Monterrey San…
DetailsOceania – Cities where the Website is accessed (08.2010 – 07.2011)
The Global Dermatology Information Portal is accessed in the following cities (top 10):
Europe – Countries where the website is accessed (08.2010 – 07.2011) The Global Dermatology Information Portal has been visited in the following countries: Albania Andorra Austria Belarus Belgium BosniaandHerzegovina Bulgaria Croatia CzechRepublic Denmark Estonia FaroeIslands Finland France Germany Greece Guernsey Hungary Iceland Ireland Italy Jersey Latvia Liechtenstein Lithuania Luxembourg Macedonia Malta Moldova Monaco Montenegro Netherlands…
DetailsAfrica – Countries where the website is accessed (08.2010 – 07.2011) The Global Dermatology Information Portal has been visited in the following countries/territories: Algeria Angola Benin Botswana BurkinaFaso Burundi Cameroon CapeVerde CentralAfricanRepublic Chad Comoros Congo (DRC and Republic) Coted’Ivoire Djibouti Egypt EquatorialGuinea Ethiopia Gabon Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Libya Madagascar Mali Mauritania Mauritius…
DetailsNorth America and South America – Countries where the website is accessed (08.2010 – 07.2011) The Global Dermatology Information Portal has been visited in the following countries/territories: Argentina Anguilla Aruba Bahamas Barbados Belize Bermuda Bolivia Brazil Canada CaymanIslands Chile Colombia Costa Rica Cuba Dominica DominicanRepublic Ecuador ElSalvador FrenchGuiana Greenland Grenada Guadeloupe Guatemala Haiti Honduras Jamaica…
DetailsUngual seborrheic keratosis. Bon-Mardion M, Poulalhon N, Balme B, Thomas L. J Eur Acad Dermatol Venereol. 2010 Sep;24(9):1102-4. Seborrheic (seborrhoeic) keratosis (SK) is seen almost daily by dermatologists and is the most common benign tumour (whether it be in the skin or not). It is a brownish “stuck on papule” initially smooth becoming darker and…
DetailsLasers Used to Treat them (For Professionals) Type of Scar and Corresponding treatment: Atrophic Scars ( en pic à glace(Icepick), rolling and boxcar scars): ablative laser (CO2 laser 10600nm, Erbium YAG 2940nm): most effective, but carries the highest risk of scarring and dyschromia. Not effective for treating sebaceous hyperplasia. fractional laser (Fractional Co2 and Erbium):…
DetailsAgeing (Aging): Observations and Solutions (For professionals) “With advancing age, skin functions deteriorate due to structural and morphologic changes. In particular, changes in skin barrier integrity, immune function, and nervous system occur, resulting in an incresaed prevalence of certain diseases. As the elderly population is rapidly increasing throughout the world, awareness of these diseases and…
DetailsCutaneous Reactions to Anti EGF Drugs and Management (For professionals) Examples of Anti-EGF drugs: Cetuximab (e.g. Erbitux): used in the treatment of Colorectal cancer. Gefitinib (e.g. Iressa): used in the treatment of Lung Cancer Erlotinib (e.g Tarceva): used in the treatment of small-cell Lung cancer, Pancreatic cancers and other cancers What is a typical reaction…
Details